DOC+ Competitors and Similar CompaniesClear all
DOC+'s competitors and similar companies include E25Bio, Verilogue, Weimai and AiiNTENSE.
 DOC+ DOC+ is a digital health company specializing in on-demand medical services, EHR, and medical data management. |  Weimai Weimai is a company developing a health application platform intended to provide medical and health services. |  AiiNTENSE AiiNTENSE is a company that offers a software solution for resuscitation clinicians for the prediction and monitoring of patients' neurological status. | |||
Founding Date | Founding Date 2015 | Founding Date 2018 | Founding Date 2006 | Founding Date 2013 | Founding Date 2018 |
Type | Type Private | Type Private | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Moskva, RU HQ | Locations Cambridge, US HQ | Locations Philadelphia, US HQ | Locations Hangzhou Shi, CN HQ | Locations Évry-Courcouronnes, FR HQ |
Employees | Employees 234 | Employees 2 | Employees 831% decrease | Employees 48 | Employees 4 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 2m (about 6 years ago) | Latest funding round N/A | Latest funding round $ 100m (almost 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 4.3m | Total funding raised N/A | Total funding raised $ 130m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
E25Bio
HQ
Cambridge, US
Employees
2
E25Bio is a provider of rapid, point-of-care, diagnostic technology.
View company
Verilogue
HQ
Philadelphia, US
Verilogue is a healthcare market research and data analytics company.
View companyWeimai
HQ
Hangzhou Shi, CN
Employees
48
Weimai is a company developing a health application platform intended to provide medical and health services.
View companyAiiNTENSE
HQ
Évry-Courcouronnes, FR
Employees
4
AiiNTENSE is a company that offers a software solution for resuscitation clinicians for the prediction and monitoring of patients' neurological status.
View company